Forest Laboratories, Inc. (FRX) - Earnings Reports, Stock Quote and Stock Chart
|
|
| Earnings Reports for FRX - Forest Laboratories, Inc. | |||||||||||||
| list date | symbol | list price | wl | rt | er | sr | pes | eps | sales (m) | epc | spc | group | avg vol |
| 04/16/08 | FRX | 36.13 | EX1 | 8 | 4 | 40 | .90/.74 | 991 / 885 | +21.6- | +12+ | MED | 3,024,000 | |
| 01/16/08 | FRX | 37.82 | X | EX1 | 8 | 4 | 39 | .96/.78 | 998 / 893 | +23.1+ | +12+ | MED | 2,911,000 |
| 10/17/07 | FRX | 38.57 | E | 8 | 1 | 45 | .86/.75 | 919 / 847 | +14.7- | +8.5- | MED | 4,295,000 | |
| 07/18/07 | FRX | 45.46 | E | 8 | 1 | 55 | .83/.62 | 928 / 816 | +33.9+ | +14- | MED | 2,940,000 | |
| 04/25/07 | FRX | 54.56 | E | 8 | 6 | 74 | .74/.65 | 885 / 756 | +13.9- | +17- | MED | 2,254,000 | |
| 01/17/07 | FRX | 53.02 | EX1 | 9 | 7 | 68 | .78/.57 | 893 / 758 | +36.5+ | +18+ | MED | 2,368,000 | |
| 10/18/06 | FRX | 52.88 | EX1 | 9 | 9 | 71 | .75/.59 | 847 / 737 | +27.1+ | +15+ | MED | 2,248,000 | |
| 07/19/06 | FRX | 42.57 | X | E | 9 | 7 | 69 | .62/.52 | 816 / 712 | +19.2- | +15- | MED | 2,162,000 |
| 04/26/06 | FRX | 40.93 | X | EX3 | 5 | 4 | 63 | .65/.40 | 756 / 653 | +62.5+ | +16+ | MED | 2,229,000 |
| 01/18/06 | frx | 43.89 | EX1 | 5 | 7 | 77 | .57/.70 | 758 / 832 | -18.6+ | -8.9+ | MED | 1,847,000 | |
| 10/19/05 | frx | 35.26 | E | 6 | 2 | 60 | .59/.79 | 737 / 881 | -25.3- | -16- | MED | 2,063,000 | |
| 07/20/05 | frx | 40.69 | X | EX1 | 7 | 3 | 78 | .52/.60 | 712 / 793 | -13.3- | -10+ | MED | 1,838,000 |
| 04/20/05 | FRX | 35.05 | E | 9 | 1 | 88 | .40/.38 | 653 / 733 | +5.3- | -11- | MED | 2,794,000 | |
| 01/19/05 | FRX | 41.79 | E | 10 | 1 | 60 | .70/.60 | 832 / 707 | +16.7- | +18- | MED | 3,451,000 | |
| 10/19/04 | FRX | 46.37 | X | EX3 | 10 | 2 | 59 | .79/.49 | 881 / 626 | +61.2+ | +41+ | MED | 2,414,000 |
| 07/21/04 | FRX | 50.20 | X | EX1 | 9 | 2 | 84 | .60/.48 | 793 / 614 | +25+ | +29+ | MED | 2,424,000 |
| 04/21/04 | frx | 69.69 | X | E | 8 | 6 | 183 | .38/.48 | 733 / 629 | -20.8 | +17- | MED | 1,939,000 |
| 01/21/04 | FRX | 73.00 | X | EX1 | 10 | 7 | 122 | .60/.47 | 707 / 594 | +27.7- | +19+ | MED | 2,259,000 |
| 10/15/03 | FRX | 47.81 | X | E | 10 | 1 | 98 | .49/.38 | 626 / 545 | +28.9- | +14.9- | MED | 3,848,000 |
| 07/16/03 | FRX | 49.25 | E | 10 | 2 | 101 | .49/.35 | 614 / 479 | +40- | +28- | MED | 3,428,000 | |
| 04/23/03 | FRX | 49.40 | E | 10 | 7 | 99 | .50/.27 | 629 / 446 | +85- | +41- | MED | 3,318,000 | |
| 01/17/03 | FRX | 53.43 | EX1 | 10 | 9 | 111 | .48/.25 | 594 / 412 | +92+ | +44+ | MED | 3,318,000 | |
| 12/16/02 | FRX | 98.42 | SS | 10 | 9 | - | - | - | - | - | MED | 2,991,000 | |
| 10/16/02 | FRX | 97.06 | X | EX2 | 10 | 9 | 123 | .79/.45 | 545 / 384 | +76+ | +42+ | MED | 2,991,000 |
| 07/18/02 | FRX | 74.49 | X | E | 10 | 6 | 108 | .69/.42 | 479 / 359 | +64+ | +33- | MED | 1,686,000 |
| 04/25/02 | FRX | 78.40 | EX1 | 10 | 5 | 145 | .54/.39 | 446 / 334 | +38+ | +34+ | MED | 1,362,000 | |
| 01/16/02 | FRX | 79.65 | X | E | 10 | 6 | 163 | .49/.38 | 412 / 318 | +29- | +30- | MED | 1,293,000 |
| 10/17/01 | FRX | 74.67 | X | E | 10 | 8 | 166 | .45/.30 | 384 / 288 | +50 | +34- | MED | 1,380,000 |
| 07/18/01 | FRX | 78.20 | X | E | 10 | 8 | 186 | .42/.16n | 359 / 266 | +163 | +35+ | MED | 1,324,000 |
| 04/25/01 | FRX | 56.81 | E | 10 | 6 | 146 | .39/.17 | 334 / 265 | +129+ | +26- | MED | 1,223,000 | |
| 01/17/01 | FRX | 62.31 | EX1 | 10 | 9 | 164 | .38/.19 | na / na | +100 | +32- | MED | 982,000 | |
| 12/18/00 | FRX | 132.87 | SS | 10 | 10 | - | - | - | - | - | MED | 888,000 | |
| 10/18/00 | FRX | 117.12 | E | 7 | 9 | 199 | .59/.33 | 288 / na | +79 | +40- | MED | 888,000 | |
| 07/19/00 | FRX | 105.43 | X | EX1 | 4 | 9 | 245 | .43/.30 | 266 / na | +43 | +42+ | MED | 685,000 |
| 05/03/00 | frx | 84.25 | E | 3 | 9 | 255 | .33/.47 | 265 / na | -30- | +38- | MED | 629,000 | |
| 01/19/00 | FRX | 62.56 | X | EX1 | 7 | 7 | 165 | .38/.26 | na / na | +46- | +56+ | MED | 599,000 |
| 10/20/99 | FRX | 47.00 | EX1 | 8 | 7 | 142 | .33/.13 | na / na | +154 | +38 | MED | 453,900 | |
| 07/21/99 | FRX | 49.88 | EX2 | 8 | 7 | 166 | .30/.08 | na / na | +275+ | +67+ | MED | 461,200 | |
| • - indicates a break in earnings coverage |
| Displaying records 1 through 38 of 38 total records. |
